Crestchem Limited: Approves Q1 FY27 Unaudited Financial Results

Crestchem Limited has announced the approval of its unaudited standalone and consolidated financial results for the quarter ended June 30, 2026. The Board of Directors reviewed and recorded these results along with a limited review report. The financial statements adhere to Indian Accounting Standards (Ind AS) and were approved following a meeting held on August 12, 2026.

Crestchem Limited Announces Quarterly Financial Results

Crestchem Limited has formally approved and recorded its unaudited standalone and consolidated financial results for the quarter that concluded on June 30, 2026. This significant corporate action was confirmed during a Board of Directors meeting held on August 12, 2026.

Key Financial Highlights

The financial results presented reflect the company’s performance for the first quarter of the financial year 2026-27. Accompanying the financial statements is a Limited Review Report, signifying that an external audit has been conducted on these interim results. The figures have been prepared in accordance with Indian Accounting Standards (Ind AS) as mandated by the Companies Act, 2013.

Standalone Financials Snapshot (Quarter Ended June 30, 2026)

  • Total Income from Operations (net): ₹917.89 Lakhs
  • Other Income: ₹19.60 Lakhs
  • Total Income: ₹937.49 Lakhs
  • Total Expenses: ₹801.30 Lakhs
  • Profit Before Tax: ₹136.19 Lakhs
  • Profit for the Period: ₹98.29 Lakhs
  • Basic Earnings Per Share (EPS): ₹3.28

Consolidated Financials Snapshot (Quarter Ended June 30, 2026)

  • Total Income from Operations (net): ₹925.69 Lakhs
  • Other Income: ₹19.60 Lakhs
  • Total Income: ₹945.29 Lakhs
  • Total Expenses: ₹813.23 Lakhs
  • Profit Before Tax: ₹132.06 Lakhs
  • Profit for the Period: ₹94.16 Lakhs
  • Basic Earnings Per Share (EPS): ₹3.14

The company operates in a single segment, Nutrition-Chemical Industries, as stated in the notes to the financial results.

Source: BSE

Previous Article

Sainik Finance: Board Committees Reconstituted After Director Changes

Next Article

Kaynes Technology: Q1 FY27 Revenue Surges 40% Driven by EMS Business